| Notes |
Michael Yeadon
Former CSO and VP, Allergy & Respiratory, Pfizer
Dr. Michael Yeadon is trained in Biochemistry & Toxicology and obtained a research-based PhD in Pharmacology from the University of Surrey. He has spent 23 years working in pharmaceutical Research and Development and is an Allergy and Respiratory Therapeutic Area expert. After Wellcome Labs, Dr Yeadon spent 16 years at Pfizer, first as Chief Scientific Officer, before holding the position of Vice-President. In 2012 he founded the biotech company Ziarco, which was acquired by Novartis in 2017.
Dr. Yeadon has published over 40 original research articles and consults and partners with biotechnology companies. Since September 2020, Dr Yeadon has publicly voiced his grave concerns about the PCR Test and the disproportionate response to the pandemic. He believes the pandemic was over in the summer.
https://web.archive.org/web/20210114132304/https://pandata.org/scientific-advisory-board/ |